Navigation Links
Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs

ing of our drug candidates. These statements involve significant risks and uncertainties, including those discussed in our annual report filed on form 10-K for the year ended June 30, 2006, our quarterly reports filed on Form 10-Q and in other reports filed by Array with the Securities and Exchange Commission. Because these statements reflect our current expectations concerning future events, our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors. These factors include, but are not limited to, our ability to continue to fund and successfully progress internal research efforts and to create effective, commercially viable drugs, our ability to achieve and maintain profitability, the extent to which the pharmaceutical and biotechnology industries are willing to in-license drug candidates for their product pipelines and to collaborate with and fund third parties on their drug discovery activities, our ability to out-license our proprietary candidates on favorable terms, risks associated with our dependence on our collaborators for the clinical development and commercialization of our out-licensed drug candidates, the ability of our collaborators and of Array to meet objectives tied to milestones and royalties, and our ability to attract and retain experienced scientists and management. We are providing this information as of June 20, 2007. We undertake no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such statements.

Contact

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
ir@arraybiopharma.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:9/23/2014)... Canada , September 23, 2014 ... and lifestyle related disorders and increasing number of foreign ... demand for probiotic in India ... as one of the most high growth potential markets ... concerns among consumers especially among the youth, changing food ...
(Date:9/23/2014)... CORALVILLE, Iowa , Sept. 23, 2014 /PRNewswire/ ... in the discovery and development of proprietary new ... received a No Objection Letter (NOL) from Health ... Canada for its lead product candidate ... hydrocodone prodrug in development for acute moderate to ...
(Date:9/23/2014)... , Sept. 23, 2014  While proton therapy recently began in the ... Ashya King , another case in the United States ... a young boy who was given just days to live now looks ... Logan Green of Arizona complained of a ... of medical treatments that will conclude Sept. 23, when he completes ...
Breaking Medicine Technology:India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 25-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 4
... The Dutch biotech company Skyline Diagnostics B.V. (Skyline) ... (Clavis) disclosed signing a research agreement. Under this agreement, ... individual Acute Myeloid Leukemia (AML) patients that may benefit ... This drug, elacytarabine, is a novel elaidic acid derivative ...
... demonstrate its continued commitment to innovative immunoglobulin (Ig) research, ... is seeking proposals for the next round of Interlaken ... program provides monetary grants and/or product supply to advance medical ... in the treatment of neurological disorders. From the ...
Cached Medicine Technology:Skyline Diagnostics and Clavis Pharma to Collaborate on Patient Selection Biomarker Discovery for Leukemia Drug elacytarabine 2CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology 2CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology 3
(Date:9/23/2014)... health care in the early 20th century, helping ... But bacteria are also constantly outsmarting science, and ... more frequently. This week,s Speaking of Chemistry focuses ... discusses the prospects for new drugs. The episode ... your pills if you feel better? Check it ...
(Date:9/23/2014)... -- Contrary to what is often assumed about single ... study from The Kinsey Institute has found that single ... sexually active as often as singles without children -- ... , The study, "Dating and Sexual Behavior Among Single ... published online in the Journal of Sex Research ...
(Date:9/23/2014)... On September 23, 2014, My Positive Perspective ... episode. Simmons is the founder of Traveler of Charleston magazine ... like to know. At the start of the interview, Deierlein ... this magazine?” Simmons replied by saying, “I had worked for ... I quit that and decided to start my own magazine ...
(Date:9/23/2014)... On September 20- 21, 2014, people from all over ... Trivedi Retreat ‘Consciousness is Power’, online as well as ... from Mahendra Trivedi and Trivedi Masters™ Dahryn Trivedi and ... In-person, group and live Energy Transmissions and also listened ... Master™ Alice Branton, where, they described about the importance ...
(Date:9/23/2014)... HealthDay Reporter MONDAY, Sept. 22, 2014 (HealthDay ... five heart attacks in men, a new study suggests. ... attacks over an average of 11 years if they drank moderately, ... weight fronts, the study found. Only about 1 percent ... But they were 86 percent less likely to have heart attacks ...
Breaking Medicine News(10 mins):Health News:Kinsey study of single parents' dating, sexual activity contradicts assumptions 2Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 2Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 3Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 3
... ... Hospital Gown prints, 251 Surgical Cap prints, Scrub Sacks, StethoSocks™, Medical Dental T-Shirts, Baseball ... , ... 2009 -- hospitalgowns.com and surgicalcaps.com launches its winter fashion season ...
... , ... The Performance Management Institute of Australia has ... new research conducted in collaboration with Associate Professor Alan Nankervis from ... University in Melbourne. The research was conducted by anonymous survey and ...
... Commercial Featuring Former CBO Director June O,Neill Decrying "Accounting ... , WASHINGTON, Nov. 11 Tomorrow (11/12) the Employment ... advertising campaign to educate the public about the unintended ... comes to health care reform. The possible dangers include ...
... CHILDREN,S HEALTH FUND ISSUES A REPORT CARD TO ... CRITICIZES THE PLANNED ELIMINATION OF CHILDREN,S ... 11 Children,s Health Fund (CHF), a national organization that ... underserved children, today issued a Report Card ...
... Mayor A.C. Wharton, sees Benefit in New Safe ,til Stable ... A.C. Wharton stands up for the outstanding Memphis-based National Bipolar ... of Tennessee Health & Science Center on November 17th at ... 305. The National Bipolar Foundation has been in the national ...
... But men much more likely to leave than women if spouse ... Cancer can put an enormous strain on a marriage, and couples ... the patient. , In fact, the odds of separation or divorce ... one with the illness, a new study shows. , The researchers ...
Cached Medicine News:Health News:Surgicalcaps.com Introduces Surgical Scrub Sacks 2Health News:Surgicalcaps.com Introduces Surgical Scrub Sacks 3Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 2Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 3Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 4Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 5Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 6Health News:The Performance Management Institute of Australia Issues a Warning for Business Leaders 7Health News:Employment Policies Institute Launches $10 Million Campaign Urging the Public to Rethink Health Care Reform 2Health News:Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low-Income Children 2Health News:Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low-Income Children 3Health News:Memphis Mayor Endorses National Bipolar Foundation 2Health News:Cancer Can Strain Marriages to Breaking Point 2
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
CataRhex PRO the portable cataract extraction system with automated capsulotomy....
Phacoemulsification system is a complete anterior segment surgical instrument. Its simplified design and unique innovations provide optimal surgical performance....
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Medicine Products: